Literature DB >> 24333312

Polyvalent immunoglobulins: challenges and perspectives.

Isabella Quinti1, Serelina Coluzzi2, Federica Pulvirenti1, Alessandro Prezzo1, Gabriella Girelli3.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24333312      PMCID： PMC3853976          DOI： 10.2450/2013.008s

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  25 in total

1.  Control of early viral and bacterial distribution and disease by natural antibodies.

Authors:  A F Ochsenbein; T Fehr; C Lutz; M Suter; F Brombacher; H Hengartner; R M Zinkernagel
Journal:  Science       Date:  1999-12-10       Impact factor: 47.728

2.  The antiinflammatory IgG.

Authors:  Srini V Kaveri; Sébastien Lacroix-Desmazes; Jagadeesh Bayry
Journal:  N Engl J Med       Date:  2008-07-17       Impact factor: 91.245

3.  Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection.

Authors:  Vincent R Bonagura; Robert Marchlewski; Amanda Cox; David W Rosenthal
Journal:  J Allergy Clin Immunol       Date:  2008-07       Impact factor: 10.793

4.  Management of primary antibody deficiency with replacement therapy: summary of guidelines.

Authors:  Chaim M Roifman; Melvin Berger; Luigi D Notarangelo
Journal:  Immunol Allergy Clin North Am       Date:  2008-11       Impact factor: 3.479

Review 5.  What is the contents of the magic draft IVIg?

Authors:  Jean-François Seite; Yehuda Shoenfeld; Pierre Youinou; Sophie Hillion
Journal:  Autoimmun Rev       Date:  2008-05-02       Impact factor: 9.754

Review 6.  Anti-inflammatory actions of intravenous immunoglobulin.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

7.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

Review 8.  Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.

Authors:  Jordan S Orange; Elham M Hossny; Catherine R Weiler; Mark Ballow; Melvin Berger; Francisco A Bonilla; Rebecca Buckley; Javier Chinen; Yehia El-Gamal; Bruce D Mazer; Robert P Nelson; Dhavalkumar D Patel; Elizabeth Secord; Ricardo U Sorensen; Richard L Wasserman; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2006-04       Impact factor: 10.793

9.  Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

Authors:  Helen Chapel; Mary Lucas; Martin Lee; Janne Bjorkander; David Webster; Bodo Grimbacher; Claire Fieschi; Vojtech Thon; Mohammad R Abedi; Lennart Hammarstrom
Journal:  Blood       Date:  2008-03-04       Impact factor: 22.113

10.  Prioritization of evidence-based indications for intravenous immunoglobulin.

Authors:  Jordan S Orange; Hans D Ochs; Charlotte Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2013-06-14       Impact factor: 8.317
View more
  4 in total

Review 1.  The demand for polyvalent immunoglobulins in Italy.

Authors:  Fabio Candura; Monica Lanzoni; Gabriele Calizzani; Samantha Profili; Stefania Vaglio; Simonetta Pupella; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

2.  Plasma-derived medicinal products: demand and clinical use.

Authors:  Giuliano Grazzini; Pier Mannuccio Mannucci; Fabrizio Oleari
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 3.  The growing importance of achieving national self-sufficiency in immunoglobulin in Italy. The emergence of a national imperative.

Authors:  Albert Farrugia; Giuliano Grazzini; Isabella Quinti; Fabio Candura; Samantha Profili; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2019-12-11       Impact factor: 3.443

4.  Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study.

Authors:  Federica Pulvirenti; Francesco Cinetto; Antonio Pecoraro; Maria Carrabba; Ludovica Crescenzi; Raffaella Neri; Livia Bonanni; Giovanna Fabio; Carlo Agostini; Giuseppe Spadaro; Stefano Tabolli; Albert Farrugia; Isabella Quinti; Cinzia Milito
Journal:  J Clin Immunol       Date:  2019-01-15       Impact factor: 8.317
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.